{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,7,8]],"date-time":"2025-07-08T04:05:01Z","timestamp":1751947501737,"version":"3.41.2"},"reference-count":48,"publisher":"Springer Science and Business Media LLC","issue":"7","license":[{"start":{"date-parts":[[2025,5,29]],"date-time":"2025-05-29T00:00:00Z","timestamp":1748476800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2025,5,29]],"date-time":"2025-05-29T00:00:00Z","timestamp":1748476800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Clin Rheumatol"],"published-print":{"date-parts":[[2025,7]]},"DOI":"10.1007\/s10067-025-07508-7","type":"journal-article","created":{"date-parts":[[2025,5,29]],"date-time":"2025-05-29T06:38:04Z","timestamp":1748500684000},"page":"2819-2828","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["Identification of therapeutic targets for psoriatic arthritis through proteomics"],"prefix":"10.1007","volume":"44","author":[{"given":"Fang","family":"Zhang","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jie","family":"Li","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Diqian","family":"Zhao","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-7218-4801","authenticated-orcid":false,"given":"Wenzhe","family":"Bai","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2025,5,29]]},"reference":[{"key":"7508_CR1","doi-asserted-by":"publisher","DOI":"10.1016\/j.berh.2021.101670","volume":"35","author":"M Kishimoto","year":"2021","unstructured":"Kishimoto M, Deshpande GA, Fukuoka K et al (2021) Clinical features of psoriatic arthritis. Best Pract Res Clin Rheumatol 35:101670. https:\/\/doi.org\/10.1016\/j.berh.2021.101670","journal-title":"Best Pract Res Clin Rheumatol"},{"key":"7508_CR2","doi-asserted-by":"publisher","first-page":"251","DOI":"10.1016\/j.jaad.2018.06.027","volume":"80","author":"F Alinaghi","year":"2019","unstructured":"Alinaghi F, Calov M, Kristensen LE et al (2019) Prevalence of psoriatic arthritis in patients with psoriasis: a systematic review and meta-analysis of observational and clinical studies. J Am Acad Dermatol 80:251-265.e19. https:\/\/doi.org\/10.1016\/j.jaad.2018.06.027","journal-title":"J Am Acad Dermatol"},{"key":"7508_CR3","doi-asserted-by":"publisher","first-page":"405","DOI":"10.1080\/1744666X.2018.1468252","volume":"14","author":"T Gudu","year":"2018","unstructured":"Gudu T, Gossec L (2018) Quality of life in psoriatic arthritis. Expert Rev Clin Immunol 14:405\u2013417. https:\/\/doi.org\/10.1080\/1744666X.2018.1468252","journal-title":"Expert Rev Clin Immunol"},{"key":"7508_CR4","doi-asserted-by":"publisher","unstructured":"Ocampo D V, Gladman D (2019) Psoriatic arthritis. F1000research 8:1665. https:\/\/doi.org\/10.12688\/f1000research.19144.1","DOI":"10.12688\/f1000research.19144.1"},{"key":"7508_CR5","doi-asserted-by":"publisher","DOI":"10.3390\/ijms24054901","volume":"24","author":"AB Azuaga","year":"2023","unstructured":"Azuaga AB, Ram\u00edrez J, Ca\u00f1ete JD (2023) Psoriatic arthritis: pathogenesis and targeted therapies. Int J Mol Sci 24:4901. https:\/\/doi.org\/10.3390\/ijms24054901","journal-title":"Int J Mol Sci"},{"key":"7508_CR6","doi-asserted-by":"publisher","first-page":"19","DOI":"10.1038\/s41576-020-0268-2","volume":"22","author":"K Suhre","year":"2021","unstructured":"Suhre K, McCarthy MI, Schwenk JM (2021) Genetics meets proteomics: perspectives for large population-based studies. Nat Rev Genet 22:19\u201337. https:\/\/doi.org\/10.1038\/s41576-020-0268-2","journal-title":"Nat Rev Genet"},{"key":"7508_CR7","doi-asserted-by":"publisher","unstructured":"Sanderson E, Glymour MM, Holmes MV et al (2022) Mendelian randomization.Nat Rev Methods Primers 2. https:\/\/doi.org\/10.1038\/s43586-021-00092-5","DOI":"10.1038\/s43586-021-00092-5"},{"key":"7508_CR8","doi-asserted-by":"publisher","first-page":"953","DOI":"10.1053\/j.gastro.2023.01.028","volume":"164","author":"J Bourgault","year":"2023","unstructured":"Bourgault J, Abner E, Manikpurage HD et al (2023) Proteome-wide mendelian randomization identifies causal links between blood proteins and acute pancreatitis. Gastroenterology 164:953-965.e3. https:\/\/doi.org\/10.1053\/j.gastro.2023.01.028","journal-title":"Gastroenterology"},{"key":"7508_CR9","doi-asserted-by":"publisher","first-page":"1205","DOI":"10.1161\/CIRCULATIONAHA.121.056663","volume":"145","author":"A Henry","year":"2022","unstructured":"Henry A, Gordillo-Mara\u00f1\u00f3n M, Finan C et al (2022) Therapeutic targets for heart failure identified using proteomics and mendelian randomization. Circulation 145:1205\u20131217. https:\/\/doi.org\/10.1161\/CIRCULATIONAHA.121.056663","journal-title":"Circulation"},{"key":"7508_CR10","doi-asserted-by":"publisher","first-page":"75","DOI":"10.1186\/s13073-023-01229-9","volume":"15","author":"J Sun","year":"2023","unstructured":"Sun J, Zhao J, Jiang F et al (2023) Identification of novel protein biomarkers and drug targets for colorectal cancer by integrating human plasma proteome with genome. Genome Med 15:75. https:\/\/doi.org\/10.1186\/s13073-023-01229-9","journal-title":"Genome Med"},{"key":"7508_CR11","doi-asserted-by":"publisher","first-page":"764","DOI":"10.1038\/s41467-020-20885-8","volume":"12","author":"CN Foley","year":"2021","unstructured":"Foley CN, Staley JR, Breen PG et al (2021) A fast and efficient colocalization algorithm for identifying shared genetic risk factors across multiple traits. Nat Commun 12:764. https:\/\/doi.org\/10.1038\/s41467-020-20885-8","journal-title":"Nat Commun"},{"key":"7508_CR12","doi-asserted-by":"publisher","first-page":"481","DOI":"10.1038\/ng.3538","volume":"48","author":"Z Zhu","year":"2016","unstructured":"Zhu Z, Zhang F, Hu H et al (2016) Integration of summary data from GWAS and eQTL studies predicts complex trait gene targets. Nat Genet 48:481\u2013487. https:\/\/doi.org\/10.1038\/ng.3538","journal-title":"Nat Genet"},{"key":"7508_CR13","doi-asserted-by":"publisher","first-page":"1535","DOI":"10.1002\/art.42154","volume":"74","author":"M Soomro","year":"2022","unstructured":"Soomro M, Stadler M, Dand N et al (2022) Comparative genetic analysis of psoriatic arthritis and psoriasis for the discovery of genetic risk factors and risk prediction modeling. Arthritis & Rheumatology 74:1535\u20131543. https:\/\/doi.org\/10.1002\/art.42154","journal-title":"Arthritis & Rheumatology"},{"key":"7508_CR14","doi-asserted-by":"publisher","first-page":"1712","DOI":"10.1038\/s41588-021-00978-w","volume":"53","author":"E Ferkingstad","year":"2021","unstructured":"Ferkingstad E, Sulem P, Atlason BA et al (2021) Large-scale integration of the plasma proteome with genetics and disease. Nat Genet 53:1712\u20131721. https:\/\/doi.org\/10.1038\/s41588-021-00978-w","journal-title":"Nat Genet"},{"key":"7508_CR15","doi-asserted-by":"publisher","first-page":"329","DOI":"10.1038\/s41586-023-06592-6","volume":"622","author":"BB Sun","year":"2023","unstructured":"Sun BB, Chiou J, Traylor M et al (2023) Plasma proteomic associations with genetics and health in the UK biobank. Nature 622:329\u2013338. https:\/\/doi.org\/10.1038\/s41586-023-06592-6","journal-title":"Nature"},{"key":"7508_CR16","doi-asserted-by":"publisher","DOI":"10.1136\/bmj.n2233","volume":"375","author":"VW Skrivankova","year":"2021","unstructured":"Skrivankova VW, Richmond RC, Woolf BAR et al (2021) Strengthening the reporting of observational studies in epidemiology using Mendelian randomisation (STROBE-MR): explanation and elaboration. BMJ (Clinical research ed) 375:n2233. https:\/\/doi.org\/10.1136\/bmj.n2233","journal-title":"BMJ (Clinical research ed)"},{"key":"7508_CR17","doi-asserted-by":"publisher","unstructured":"Davies NM, Holmes MV, Davey Smith G (2018) Reading Mendelian randomisation studies: a guide, glossary, and checklist for clinicians. BMJ k601. https:\/\/doi.org\/10.1136\/bmj.k601","DOI":"10.1136\/bmj.k601"},{"key":"7508_CR18","doi-asserted-by":"publisher","first-page":"740","DOI":"10.1093\/ije\/dyq151","volume":"40","author":"BL Pierce","year":"2011","unstructured":"Pierce BL, Ahsan H, VanderWeele TJ (2011) Power and instrument strength requirements for Mendelian randomization studies using multiple genetic variants. Int J Epidemiol 40:740\u2013752. https:\/\/doi.org\/10.1093\/ije\/dyq151","journal-title":"Int J Epidemiol"},{"key":"7508_CR19","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1086\/321275","volume":"69","author":"JK Pritchard","year":"2001","unstructured":"Pritchard JK, Przeworski M (2001) Linkage disequilibrium in humans: models and data. The American Journal of Human Genetics 69:1\u201314. https:\/\/doi.org\/10.1086\/321275","journal-title":"The American Journal of Human Genetics"},{"key":"7508_CR20","doi-asserted-by":"publisher","first-page":"56","DOI":"10.1038\/nature11632","volume":"491","author":"GR Abecasis","year":"2012","unstructured":"Genomes Project Consortium, Abecasis GR, Auton A et al (2012) An integrated map of genetic variation from 1,092 human genomes. Nature 491:56\u201365. https:\/\/doi.org\/10.1038\/nature11632","journal-title":"Nature"},{"key":"7508_CR21","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pgen.1007081","volume":"13","author":"G Hemani","year":"2017","unstructured":"Hemani G, Tilling K, Davey Smith G (2017) Orienting the causal relationship between imprecisely measured traits using GWAS summary data. PLoS Genet 13:e1007081. https:\/\/doi.org\/10.1371\/journal.pgen.1007081","journal-title":"PLoS Genet"},{"key":"7508_CR22","doi-asserted-by":"publisher","first-page":"1177","DOI":"10.1093\/aje\/kwt084","volume":"178","author":"BL Pierce","year":"2013","unstructured":"Pierce BL, Burgess S (2013) Efficient design for Mendelian randomization studies: subsample and 2-sample instrumental variable estimators. Am J Epidemiol 178:1177\u20131184. https:\/\/doi.org\/10.1093\/aje\/kwt084","journal-title":"Am J Epidemiol"},{"key":"7508_CR23","doi-asserted-by":"publisher","first-page":"658","DOI":"10.1002\/gepi.21758","volume":"37","author":"S Burgess","year":"2013","unstructured":"Burgess S, Butterworth A, Thompson SG (2013) Mendelian Randomization analysis with multiple genetic variants using summarized data. Genet Epidemiol 37:658\u2013665. https:\/\/doi.org\/10.1002\/gepi.21758","journal-title":"Genet Epidemiol"},{"key":"7508_CR24","doi-asserted-by":"publisher","first-page":"512","DOI":"10.1093\/ije\/dyv080","volume":"44","author":"J Bowden","year":"2015","unstructured":"Bowden J, Davey Smith G, Burgess S (2015) Mendelian randomization with invalid instruments: effect estimation and bias detection through Egger regression. Int J Epidemiol 44:512\u2013525. https:\/\/doi.org\/10.1093\/ije\/dyv080","journal-title":"Int J Epidemiol"},{"key":"7508_CR25","doi-asserted-by":"publisher","first-page":"304","DOI":"10.1002\/gepi.21965","volume":"40","author":"J Bowden","year":"2016","unstructured":"Bowden J, Davey Smith G, Haycock PC, Burgess S (2016) Consistent estimation in Mendelian randomization with some invalid instruments using a weighted median estimator. Genet Epidemiol 40:304\u2013314. https:\/\/doi.org\/10.1002\/gepi.21965","journal-title":"Genet Epidemiol"},{"key":"7508_CR26","doi-asserted-by":"publisher","first-page":"289","DOI":"10.1111\/j.2517-6161.1995.tb02031.x","volume":"57","author":"Y Benjamini","year":"1995","unstructured":"Benjamini Y, Hochberg Y (1995) Controlling the false discovery rate: a practical and powerful approach to multiple testing. J Roy Stat Soc: Ser B (Methodol) 57:289\u2013300. https:\/\/doi.org\/10.1111\/j.2517-6161.1995.tb02031.x","journal-title":"J Roy Stat Soc: Ser B (Methodol)"},{"key":"7508_CR27","doi-asserted-by":"publisher","first-page":"2926","DOI":"10.1002\/sim.6522","volume":"34","author":"MFD Greco","year":"2015","unstructured":"Greco MFD, Minelli C, Sheehan NA, Thompson JR (2015) Detecting pleiotropy in mendelian randomisation studies with summary data and a continuous outcome. Stat Med 34:2926\u20132940. https:\/\/doi.org\/10.1002\/sim.6522","journal-title":"Stat Med"},{"key":"7508_CR28","doi-asserted-by":"publisher","unstructured":"Verbanck M, Chen CY, Neale B, Do R (2018) Detection of widespread horizontal pleiotropy in causal relationships inferred from mendelian randomization between complex traits and diseases. Nat Genet 50. https:\/\/doi.org\/10.1038\/s41588-018-0099-7","DOI":"10.1038\/s41588-018-0099-7"},{"key":"7508_CR29","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pgen.1004383","volume":"10","author":"C Giambartolomei","year":"2014","unstructured":"Giambartolomei C, Vukcevic D, Schadt EE et al (2014) Bayesian test for colocalisation between pairs of genetic association studies using summary statistics. PLoS Genet 10:e1004383. https:\/\/doi.org\/10.1371\/journal.pgen.1004383","journal-title":"PLoS Genet"},{"key":"7508_CR30","doi-asserted-by":"publisher","first-page":"918","DOI":"10.1038\/s41467-018-03371-0","volume":"9","author":"Y Wu","year":"2018","unstructured":"Wu Y, Zeng J, Zhang F et al (2018) Integrative analysis of omics summary data reveals putative mechanisms underlying complex traits. Nat Commun 9:918. https:\/\/doi.org\/10.1038\/s41467-018-03371-0","journal-title":"Nat Commun"},{"key":"7508_CR31","doi-asserted-by":"publisher","first-page":"1826","DOI":"10.1038\/s41467-017-01261-5","volume":"8","author":"K Watanabe","year":"2017","unstructured":"Watanabe K, Taskesen E, van Bochoven A, Posthuma D (2017) Functional mapping and annotation of genetic associations with FUMA. Nat Commun 8:1826. https:\/\/doi.org\/10.1038\/s41467-017-01261-5","journal-title":"Nat Commun"},{"key":"7508_CR32","doi-asserted-by":"publisher","first-page":"D638","DOI":"10.1093\/nar\/gkac1000","volume":"51","author":"D Szklarczyk","year":"2022","unstructured":"Szklarczyk D, Kirsch R, Koutrouli M et al (2022) The STRING database in 2023: protein\u2013protein association networks and functional enrichment analyses for any sequenced genome of interest. Nucleic Acids Res 51:D638\u2013D646. https:\/\/doi.org\/10.1093\/nar\/gkac1000","journal-title":"Nucleic Acids Res"},{"key":"7508_CR33","doi-asserted-by":"publisher","first-page":"D1265","DOI":"10.1093\/nar\/gkad976","volume":"52","author":"C Knox","year":"2024","unstructured":"Knox C, Wilson M, Klinger CM et al (2024) DrugBank 6.0: the DrugBank knowledgebase for 2024. Nucleic Acids Res 52:D1265\u2013D1275. https:\/\/doi.org\/10.1093\/nar\/gkad976","journal-title":"Nucleic Acids Res"},{"key":"7508_CR34","doi-asserted-by":"publisher","first-page":"369","DOI":"10.5114\/aoms.2018.74021","volume":"15","author":"A Pietrzak","year":"2019","unstructured":"Pietrzak A, Chabros P, Grywalska E et al (2019) Serum lipid metabolism in psoriasis and psoriatic arthritis \u2013 an update. Archives of Medical Science\u202f: AMS 15:369\u2013375. https:\/\/doi.org\/10.5114\/aoms.2018.74021","journal-title":"Archives of Medical Science : AMS"},{"key":"7508_CR35","doi-asserted-by":"publisher","first-page":"194","DOI":"10.1097\/MOL.0000000000000688","volume":"31","author":"Y Liu","year":"2020","unstructured":"Liu Y, Morton RE (2020) Apolipoprotein F - a natural inhibitor of CETP and key regulator of lipoprotein metabolism. Curr Opin Lipidol 31:194\u2013199. https:\/\/doi.org\/10.1097\/MOL.0000000000000688","journal-title":"Curr Opin Lipidol"},{"key":"7508_CR36","doi-asserted-by":"publisher","first-page":"40","DOI":"10.1161\/ATVBAHA.108.177105","volume":"29","author":"WR Lagor","year":"2009","unstructured":"Lagor WR, Brown RJ, Toh S-A et al (2009) Overexpression of apolipoprotein F reduces HDL cholesterol levels in vivo. Arterioscler Thromb Vasc Biol 29:40\u201346. https:\/\/doi.org\/10.1161\/ATVBAHA.108.177105","journal-title":"Arterioscler Thromb Vasc Biol"},{"key":"7508_CR37","first-page":"2440","volume":"33","author":"E Spanakis","year":"2006","unstructured":"Spanakis E, Sidiropoulos P, Papadakis J et al (2006) Modest but sustained increase of serum high density lipoprotein cholesterol levels in patients with inflammatory arthritides treated with infliximab. J Rheumatol 33:2440\u20132446","journal-title":"J Rheumatol"},{"key":"7508_CR38","doi-asserted-by":"publisher","DOI":"10.3390\/life14030395","volume":"14","author":"P Guerra","year":"2024","unstructured":"Guerra P, Di Cesare A, Rosi E et al (2024) Effects on lipid profile after one year of apremilast therapy in patients with psoriasis: a monocentric experience. Life (Basel, Switzerland) 14:395. https:\/\/doi.org\/10.3390\/life14030395","journal-title":"Life (Basel, Switzerland)"},{"key":"7508_CR39","doi-asserted-by":"publisher","first-page":"261","DOI":"10.1186\/s13075-016-1148-1","volume":"18","author":"S Hassan","year":"2016","unstructured":"Hassan S, Milman U, Feld J et al (2016) Effects of anti-TNF-\u03b1 treatment on lipid profile in rheumatic diseases: an analytical cohort study. Arthritis Res Ther 18:261. https:\/\/doi.org\/10.1186\/s13075-016-1148-1","journal-title":"Arthritis Res Ther"},{"key":"7508_CR40","doi-asserted-by":"publisher","first-page":"1387","DOI":"10.1002\/acr.23930","volume":"71","author":"DD Gladman","year":"2019","unstructured":"Gladman DD, Charles-Schoeman C, McInnes IB et al (2019) Changes in lipid levels and incidence of cardiovascular events following tofacitinib treatment in patients with psoriatic arthritis: a pooled analysis across phase III and long-term extension studies. Arthrit Care Res 71:1387\u20131395. https:\/\/doi.org\/10.1002\/acr.23930","journal-title":"Arthrit Care Res"},{"key":"7508_CR41","doi-asserted-by":"publisher","first-page":"218","DOI":"10.1074\/jbc.M806267200","volume":"284","author":"W Li","year":"2009","unstructured":"Li W, Danilenko DM, Bunting S et al (2009) The serine protease marapsin is expressed in stratified squamous epithelia and is up-regulated in the hyperproliferative epidermis of psoriasis and regenerating wounds *. J Biol Chem 284:218\u2013228. https:\/\/doi.org\/10.1074\/jbc.M806267200","journal-title":"J Biol Chem"},{"key":"7508_CR42","doi-asserted-by":"publisher","first-page":"2073","DOI":"10.2174\/0929867330666230324161329","volume":"31","author":"Y Xu","year":"2024","unstructured":"Xu Y, Shen Y, Bhandari A et al (2024) Serine protease 27, a prognostic biomarker in pan-cancer and associated with the aggressive progression of breast cancer. Curr Med Chem 31:2073\u20132089. https:\/\/doi.org\/10.2174\/0929867330666230324161329","journal-title":"Curr Med Chem"},{"key":"7508_CR43","doi-asserted-by":"publisher","DOI":"10.3389\/fimmu.2021.637829","volume":"12","author":"C Schinocca","year":"2021","unstructured":"Schinocca C, Rizzo C, Fasano S et al (2021) Role of the IL-23\/IL-17 pathway in rheumatic diseases: an overview. Front Immunol 12:637829. https:\/\/doi.org\/10.3389\/fimmu.2021.637829","journal-title":"Front Immunol"},{"key":"7508_CR44","doi-asserted-by":"publisher","first-page":"680","DOI":"10.1016\/j.immuni.2011.05.003","volume":"34","author":"Y-M Loo","year":"2011","unstructured":"Loo Y-M, Gale M (2011) Immune signaling by RIG-I-like receptors. Immunity 34:680\u2013692. https:\/\/doi.org\/10.1016\/j.immuni.2011.05.003","journal-title":"Immunity"},{"key":"7508_CR45","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0128262","volume":"10","author":"M Dolcino","year":"2015","unstructured":"Dolcino M, Ottria A, Barbieri A et al (2015) Gene expression profiling in peripheral blood cells and synovial membranes of patients with psoriatic arthritis. PLoS ONE 10:e0128262. https:\/\/doi.org\/10.1371\/journal.pone.0128262","journal-title":"PLoS ONE"},{"key":"7508_CR46","doi-asserted-by":"publisher","unstructured":"Zhu H, Lou F, Yin Q et al (2017) RIG\u2010I antiviral signaling drives interleukin\u201023 production and psoriasis\u2010like skin disease. Embo Mol Med 9:589\u2013604. https:\/\/doi.org\/10.15252\/emmm.201607027","DOI":"10.15252\/emmm.201607027"},{"key":"7508_CR47","doi-asserted-by":"publisher","first-page":"214","DOI":"10.1038\/nrrheum.2018.31","volume":"14","author":"TLW Muskardin","year":"2018","unstructured":"Muskardin TLW, Niewold TB (2018) Type I interferon in rheumatic diseases. Nat Rev Rheumatol 14:214\u2013228. https:\/\/doi.org\/10.1038\/nrrheum.2018.31","journal-title":"Nat Rev Rheumatol"},{"key":"7508_CR48","doi-asserted-by":"publisher","first-page":"e557","DOI":"10.1111\/jdv.19701","volume":"38","author":"H Bachelez","year":"2024","unstructured":"Bachelez H, Griffiths CEM, Papp KA et al (2024) Tofacitinib efficacy, patient-reported outcomes and safety in patients with psoriasis and a medical history of psoriatic arthritis: pooled analysis of two phase III studies. Journal of the European Academy of Dermatology and Venereology: JEADV 38:e557\u2013e561. https:\/\/doi.org\/10.1111\/jdv.19701","journal-title":"Journal of the European Academy of Dermatology and Venereology: JEADV"}],"container-title":["Clinical Rheumatology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s10067-025-07508-7.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s10067-025-07508-7\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s10067-025-07508-7.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,7,7]],"date-time":"2025-07-07T07:46:29Z","timestamp":1751874389000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s10067-025-07508-7"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,5,29]]},"references-count":48,"journal-issue":{"issue":"7","published-print":{"date-parts":[[2025,7]]}},"alternative-id":["7508"],"URL":"https:\/\/doi.org\/10.1007\/s10067-025-07508-7","relation":{},"ISSN":["0770-3198","1434-9949"],"issn-type":[{"type":"print","value":"0770-3198"},{"type":"electronic","value":"1434-9949"}],"subject":[],"published":{"date-parts":[[2025,5,29]]},"assertion":[{"value":"24 February 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"6 May 2025","order":2,"name":"revised","label":"Revised","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"20 May 2025","order":3,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"29 May 2025","order":4,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"None.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Disclosures"}}]}}